Parallel Advisors, LLC Baxter International Inc Transaction History

Parallel Advisors, LLC

  • $4.18 Billion
  • Q3 2024

A detailed history of Parallel Advisors, LLC transactions in Baxter International Inc stock. As of the latest transaction made, Parallel Advisors, LLC holds 4,790 shares of BAX stock, worth $141,305. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,790
Previous 3,370 42.14%
Holding current value
$141,305
Previous $112,000 61.61%
% of portfolio
0.0%
Previous 0.0%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$32.85 - $40.26 $46,647 - $57,169
1,420 Added 42.14%
4,790 $181,000
Q2 2024

Aug 08, 2024
SELL
$32.87 - $43.55 $27,282 - $36,146
-830 Reduced 19.76%
3,370 $112,000
Q1 2024

May 06, 2024
BUY
$37.88 - $43.77 $6,212 - $7,178
164 Added 4.06%
4,200 $179,000
Q4 2023

Feb 09, 2024
BUY
$31.71 - $38.95 $1,934 - $2,375
61 Added 1.53%
4,036 $156,000
Q3 2023

May 20, 2024
SELL
$37.32 - $49.29 $103,563 - $136,779
-2,775 Reduced 41.11%
3,975 $150,000
Q3 2023

Nov 13, 2023
SELL
$37.32 - $49.29 $103,563 - $136,779
-2,775 Reduced 41.11%
3,975 $150,000
Q2 2023

May 20, 2024
BUY
$39.98 - $47.68 $5,517 - $6,579
138 Added 2.09%
6,750 $307,000
Q2 2023

Aug 04, 2023
BUY
$39.98 - $47.68 $5,517 - $6,579
138 Added 2.09%
6,750 $307,000
Q1 2023

May 20, 2024
BUY
$37.58 - $52.57 $90,642 - $126,798
2,412 Added 57.43%
6,612 $268,000
Q1 2023

Apr 25, 2023
BUY
$37.58 - $52.57 $123,375 - $172,587
3,283 Added 98.62%
6,612 $268,000
Q4 2022

Feb 03, 2023
SELL
$49.7 - $57.71 $67,144 - $77,966
-1,351 Reduced 28.87%
3,329 $169,000
Q3 2022

Nov 10, 2022
SELL
$53.86 - $66.8 $16,211 - $20,106
-301 Reduced 6.04%
4,680 $252,000
Q2 2022

Aug 01, 2022
SELL
$63.83 - $80.0 $43,149 - $54,080
-676 Reduced 11.95%
4,981 $320,000
Q1 2022

Apr 28, 2022
SELL
$76.85 - $89.45 $132,719 - $154,480
-1,727 Reduced 23.39%
5,657 $449,000
Q4 2021

Jan 20, 2022
BUY
$74.57 - $87.19 $26,174 - $30,603
351 Added 4.99%
7,384 $634,000
Q3 2021

Nov 02, 2021
BUY
$73.77 - $83.61 $16,450 - $18,645
223 Added 3.27%
7,033 $566,000
Q2 2021

Aug 06, 2021
BUY
$80.5 - $88.01 $65,446 - $71,552
813 Added 13.56%
6,810 $548,000
Q1 2021

Apr 23, 2021
BUY
$76.38 - $86.03 $26,351 - $29,680
345 Added 6.1%
5,997 $506,000
Q4 2020

Feb 02, 2021
SELL
$75.39 - $82.36 $19,601 - $21,413
-260 Reduced 4.4%
5,652 $453,000
Q3 2020

Oct 27, 2020
SELL
$78.33 - $90.73 $20,522 - $23,771
-262 Reduced 4.24%
5,912 $475,000
Q2 2020

Jul 16, 2020
SELL
$78.66 - $94.14 $14,866 - $17,792
-189 Reduced 2.97%
6,174 $531,000
Q1 2020

Apr 27, 2020
BUY
$71.57 - $93.3 $37,717 - $49,169
527 Added 9.03%
6,363 $516,000
Q4 2019

Jan 30, 2020
SELL
$76.7 - $88.45 $88,818 - $102,425
-1,158 Reduced 16.56%
5,836 $488,000
Q3 2019

Nov 01, 2019
BUY
$81.4 - $89.78 $15,954 - $17,596
196 Added 2.88%
6,994 $612,000
Q2 2019

Aug 05, 2019
SELL
$73.44 - $82.41 $4,112 - $4,614
-56 Reduced 0.82%
6,798 $557,000
Q1 2019

May 01, 2019
SELL
$64.48 - $81.31 $19,730 - $24,880
-306 Reduced 4.27%
6,854 $557,000
Q4 2018

Feb 05, 2019
BUY
$61.45 - $77.8 $8,357 - $10,580
136 Added 1.94%
7,160 $471,000
Q3 2018

Nov 01, 2018
BUY
$70.71 - $77.75 $70 - $77
1 Added 0.01%
7,024 $541,000
Q2 2018

Jul 30, 2018
SELL
$63.43 - $75.41 $19,980 - $23,754
-315 Reduced 4.29%
7,023 $518,000
Q1 2018

May 08, 2018
SELL
$62.56 - $72.26 $26,462 - $30,565
-423 Reduced 5.45%
7,338 $477,000
Q3 2017

Nov 15, 2017
BUY
$59.5 - $64.61 $461,779 - $501,438
7,761 New
7,761 $500,000
Q3 2017

Nov 14, 2017
SELL
$59.5 - $64.61 $471,716 - $512,228
-7,928 Closed
0 $0
Q2 2017

Aug 07, 2017
BUY
N/A
7,928
7,928 $479,000

Others Institutions Holding BAX

# of Institutions
1,007
Shares Held
450M
Call Options Held
2.79M
Put Options Held
2.44M
View Full List

About BAXTER INTERNATIONAL INC

BAX Quotes by TradingView
  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $14.9B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email